Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora
Provided By PR Newswire
Last update: Jul 15, 2025
Agreement with global pharmaceutical solutions provider enhances commercial infrastructure and reinforces launch readiness for FDA-approved immunotherapy LYMPHIR™
Read more at prnewswire.com1.72
-0.09 (-4.97%)
1.25
+0.02 (+1.63%)
Find more stocks in the Stock Screener
